The Launch Trajectory Crash
Your launch looked perfect on paper. But the actual trajectory is plummeting toward failure.
Launch Trajectory Analysis
Projected vs actual market penetration
Why Launches Crash
Payer Friction
You won FDA approval but lost the payer battle. Step therapy requirements, prior auth delays, and formulary restrictions are killing your uptake.
Field Force Misfire
Your reps are calling on the wrong doctors with the wrong message. Territory alignment is off, and your share-of-voice is diluted across too many targets.
Competitive Ambush
Competitors launched counter-campaigns before your product hit the market. They're framing the narrative, and you're playing defense from day one.
The Launch Reality
Course Correct Before Impact
SlideStrike transforms launch metrics into real-time trajectory analysis that shows exactly where you're off course.
Real-Time Trajectory Tracking
Root Cause Analytics
Launch Performance FAQ
QWhat causes most product launches to underperform?
The top causes are: inadequate payer coverage (38%), poor field force deployment (25%), competitive response (20%), and messaging that doesn't resonate with prescribers (17%).
QHow quickly can you tell if a launch is failing?
Early warning signs appear within 30-60 days: script velocity, payer wins, and rep call patterns. Most companies don't have real-time visibility and realize too late.
QWhat is the cost of a failed launch?
A major pharma launch failure can cost $500M-2B in lost revenue over the product lifecycle. This includes sunk launch costs, lost market position, and reduced peak sales potential.
QCan a failing launch be course-corrected?
Yes, if caught early. Mid-launch pivots on messaging, field deployment, and payer strategy can recover 40-60% of lost trajectory. After 6 months, recovery becomes exponentially harder.
Save Your Launch. Protect Your Revenue.
See how SlideStrike helps CCOs identify and correct launch trajectory failures before they become catastrophic.
Request Launch Trajectory Demo